Faricimab (neovascular (wet) age-related macular degeneration): Solution for intravitreal injection 28.8 mg in 0.24 mL; Vabysmo® – May 2022
Page last updated: 26 August 2022
Page last updated: 26 August 2022
© Commonwealth of Australia
ABN: 83 605 426 759